Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients

View source ↗

Summary

This clinical trial update indicates ongoing recruitment for a study evaluating tacrolimus and risk factors for glucose metabolism disorders in kidney transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chiesi Poland Sp. z o.o. | Conditions: Kidney Transplant | Status: RECRUITING